OTC Pharmaceuticals - Uruguay

  • Uruguay
  • Revenue in the OTC Pharmaceuticals market amounts to US$282.00m in 2024. The market is expected to grow annually by 5.51% (CAGR 2024-2029).
  • The market's largest segment is the segment Analgesics with a market volume of US$74.63m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$82.37 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.2% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Uruguay has been experiencing steady growth over the past few years.

Customer preferences:
Customers in Uruguay have shown a growing preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC medications do not require a prescription, allowing customers to easily purchase them from pharmacies or supermarkets. This convenience is particularly appealing to busy individuals who may not have the time to visit a doctor for minor ailments. Moreover, OTC medications often offer a more affordable option compared to prescription drugs, making them a popular choice among price-conscious consumers.

Trends in the market:
One key trend in the OTC Pharmaceuticals market in Uruguay is the increasing demand for self-care and preventive healthcare. As people become more health-conscious, they are actively seeking ways to maintain their well-being and prevent illnesses. This has led to a rise in the consumption of OTC medications, such as vitamins, supplements, and preventive treatments. Additionally, the aging population in Uruguay has contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions that can be managed with OTC products.

Local special circumstances:
Uruguay has a well-developed healthcare system that provides universal coverage to its citizens. However, due to the limited resources and budget constraints, the government has been encouraging self-care and the use of OTC medications for minor ailments. This has created a favorable environment for the OTC Pharmaceuticals market to thrive. Additionally, the high literacy rate in Uruguay has played a role in the growth of the market, as consumers are more informed and empowered to make their own healthcare decisions.

Underlying macroeconomic factors:
Uruguay has experienced stable economic growth in recent years, which has positively impacted the OTC Pharmaceuticals market. As the economy improves, consumers have more disposable income to spend on healthcare products, including OTC medications. Furthermore, the increasing urbanization and changing lifestyle patterns in Uruguay have contributed to the growth of the market. Urban dwellers often have access to a wider range of OTC medications and are more likely to prioritize their health and well-being. In conclusion, the OTC Pharmaceuticals market in Uruguay is witnessing steady growth due to customer preferences for convenience and affordability, as well as the increasing demand for self-care and preventive healthcare. The local special circumstances, such as the government's encouragement of self-care and the high literacy rate, have created a favorable environment for the market. The underlying macroeconomic factors, including stable economic growth and changing lifestyle patterns, have also contributed to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)